Blood Culture-Positive Typhoid Fever Cases Respond Well to Cefixime, Ofloxacin and Azithromycin
View
Safety and Efficacy of long-term treatment with teneligliptin: Analysis of a postmarketing surveillance (PMS) of more than 10,000 Asian patients with type 2 diabetes mellitus (T2DM
View
Potential of angiotensin II receptor blockers (ARBs) in the treatment of diabetic retinopathy
View
The Glycemic Pentad: A Key Element in Management of Type 2 Diabetes
View
Teneligliptin is non-inferior to sitagliptin for type 2 diabetes (T2DM) inadequately controlled with metformin and glimepiride
View
An Open Label, 2 Year Long Term Follow-Up Study to Assess the Efficacy, Safety and Tolerability of Teneligliptin in Indian Subjects with Type 2 Diabetes Mellitus.
View
A Meta-Analysis and Systematic Review of the Efficacy of Twice Daily (BID) PPIs versus Once Daily (QD) for Treatment of Gastroesophageal Reflux Disease (GERD).
View
Efficacy and Safety of Teneligliptin in Indian Patients with Inadequately Controlled Type 2 Diabetes Mellitus: A Randomized, Double-blind Study.
View
Is metformin still the most efficacious first-line oral hypoglycaemic drug in treating type 2 diabetes? A network meta-analysis of randomized controlled trials (RCTs).
View